Search Results - "BOUW, Rene"

Refine Results
  1. 1
  2. 2

    Time‐dependent clearance of mycophenolic acid in renal transplant recipients by Van Hest, Reinier M., Van Gelder, Teun, Bouw, René, Goggin, Timothy, Gordon, Robert, Mamelok, Richard D., Mathot, Ron A.

    Published in British journal of clinical pharmacology (01-06-2007)
    “…Aims Pharmacokinetic studies of the immunosuppressive compound mycophenolic acid (MPA) have shown a structural decrease in clearance (CL) over time after renal…”
    Get full text
    Journal Article
  3. 3

    Mycophenolic Acid Exposure after Administration of Mycophenolate Mofetil in the Presence and Absence of Ciclosporin in Renal Transplant Recipients by Kuypers, Dirk R., Ekberg, Henrik, Grinyó, Josep, Nashan, Björn, Vincenti, Flavio, Snell, Paul, Mamelok, Richard D., Bouw, Rene M.

    Published in Clinical pharmacokinetics (01-05-2009)
    “…Background and objective: The pharmacokinetics of mycophenolic acid (MPA) are complex, with large interindividual variability over time. There are also well…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Methodological aspects of the use of a calibrator in in vivo microdialysis-further development of the retrodialysis method by BOUW, M. R, HAMMARLUND-UDENAES, M

    Published in Pharmaceutical research (01-11-1998)
    “…To investigate the performance of two alternative retrodialysis recovery methods and to describe the influence of different recoveries on the reliability in…”
    Get full text
    Journal Article
  6. 6

    Clinical pharmacokinetic and pharmacodynamic profile of midazolam nasal spray by Bouw, M. René, Chung, Steve S., Gidal, Barry, King, Aliceson, Tomasovic, Jerry, Wheless, James W., Van Ess, Peter J.

    Published in Epilepsy research (01-03-2021)
    “…•Nasally administered midazolam is rapidly, consistently, and extensively absorbed.•Alertness and psychomotor functionality return to baseline by ∼240 min post…”
    Get full text
    Journal Article
  7. 7

    Concentrations of Gemifloxacin at the Target Site in Healthy Volunteers after a Single Oral Dose by ISLINGER, Florian, BOUW, Rene, STAHL, Mathias, LACKNER, Edith, ZELENY, Petra, BRUNNER, Martin, MÜLLER, Markus, EICHLER, Hans Georg, JOUKHADAR, Christian

    Published in Antimicrobial Agents and Chemotherapy (01-11-2004)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  8. 8

    Phase I study assessing the safety, tolerability, and pharmacokinetics of avibactam and ceftazidime–avibactam in healthy Japanese volunteers by Tominaga, Nobumitsu, Edeki, Timi, Li, James, Learoyd, Maria, Bouw, M. René, Das, Shampa

    “…Abstract Avibactam is a novel non-β-lactam β-lactamase inhibitor that has been shown to restore the in vitro activity of ceftazidime against pathogens…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Pharmacokinetic-pharmacodynamic modelling of morphine transport across the blood-brain barrier as a cause of the antinociceptive effect delay in rats: A microdialysis study by BOUW, M. René, GARDMARK, Marie, HAMMARLUND-UDENAES, Margareta

    Published in Pharmaceutical research (01-10-2000)
    “…To quantify the contribution of distributional processes across the blood-brain barrier (BBB) to the delay in antinociceptive effect of morphine in rats…”
    Get full text
    Journal Article
  11. 11

    Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients by Pescovitz, Mark D., Vincenti, Flavio, Hart, Marquis, Melton, Larry, Whelchel, John, Mulgaonkar, Shamkant, McKay, Diane, Leung, Mimi, Calleja, Elizabeth, Bouw, M. René

    Published in British journal of clinical pharmacology (01-12-2007)
    “…Aims To compare the pharmacokinetics of mycophenolic acid (MPA) and its metabolite (MPAG) when mycophenolate mofetil (MMF) is administered in combination with…”
    Get full text
    Journal Article
  12. 12

    Safety and pharmacokinetics of daclizumab in pediatric renal transplant recipients by Pescovitz, Mark D., Knechtle, Stuart, Alexander, Steven R., Colombani, Paul, Nevins, Tom, Nieforth, Keith, Bouw, M. René

    Published in Pediatric transplantation (01-06-2008)
    “…:  This study examined the safety and pharmacokinetics/pharmacodynamics of daclizumab in combination with mycophenolate mofetil (or azathioprine),…”
    Get full text
    Journal Article
  13. 13

    Pharmacodynamics of oral ganciclovir and valganciclovir in solid organ transplant recipients by WILTSHIRE, Hugh, PAYA, Carlos V, ZUIDEVELD, Klaas P, PESCOVITZ, Mark D, HUMAR, Atul, DOMINGUEZ, Edward, WASHBURN, Kenneth, BLUMBERG, Emily, ALEXANDER, Barbara, FREEMAN, Richard, HEATON, Nigel

    Published in Transplantation (15-06-2005)
    “…A randomized, double-blind study was conducted to evaluate the pharmacokinetics of ganciclovir following oral administration of ganciclovir or valganciclovir…”
    Get full text
    Journal Article
  14. 14

    Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine by Lobritto, Steven J., Rosenthal, Philip, Bouw, Rene, Leung, Mimi, Snell, Paul, Mamelok, Richard D.

    Published in Liver transplantation (01-11-2007)
    “…There are few pharmacokinetic data for mycophenolate mofetil (MMF) when used in combination with cyclosporine (CsA) in pediatric liver transplant recipients…”
    Get full text
    Journal Article
  15. 15

    Development of a Predictive Limited Sampling Strategy for Estimation of Mycophenolic Acid Area Under the Concentration Time Curve in Patients Receiving Concomitant Sirolimus or Cyclosporine by FIGURSKI, Michal J, NAWROCKI, Artur, PESCOVITZ, Mark D, BOUW, Rene, SHAW, Leslie M

    Published in Therapeutic drug monitoring (01-08-2008)
    “…Limited sampling strategies for estimation of the area under the concentration time curve (AUC) for mycophenolic acid (MPA) co-administered with sirolimus…”
    Get full text
    Journal Article
  16. 16

    Blood‐brain barrier transport and brain distribution of morphine‐6‐glucuronide in relation to the antinociceptive effect in rats – pharmacokinetic/pharmacodynamic modelling by Bouw, M René, Xie, Rujia, Tunblad, Karin, Hammarlund‐Udenaes, Margareta

    Published in British journal of pharmacology (01-12-2001)
    “…The objective of this study was to investigate the contribution of the blood‐brain barrier (BBB) transport to the delay in antinociceptive effect of…”
    Get full text
    Journal Article
  17. 17

    Mycophenolic acid exposure after administration of mycophenolate mofetil in the presence and absence of cyclosporin in renal transplant recipients by Kuypers, Dirk R, Ekberg, Henrik, Grinyó, Josep, Nashan, Björn, Vincenti, Flavio, Snell, Paul, Mamelok, Richard D, Bouw, Rene M

    Published in Clinical pharmacokinetics (2009)
    “…The pharmacokinetics of mycophenolic acid (MPA) are complex, with large interindividual variability over time. There are also well documented interactions with…”
    Get full text
    Journal Article
  18. 18

    Modelling of the blood‐brain barrier transport of morphine‐3‐glucuronide studied using microdialysis in the rat: involvement of probenecid‐sensitive transport by Xie, Rujia, Bouw, M René, Hammarlund‐Udenaes, Margareta

    Published in British journal of pharmacology (01-12-2000)
    “…The objective of this study was to investigate the impact of probenecid on the blood‐brain barrier (BBB) transport of morphine‐3‐glucuronide (M3G). Two groups…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Assessment of type I error rates for the statistical sub-model in NONMEM by WÄHLBY, Ulrika, BOUW, M. Rene, JONSSON, E. Niclas, KARLSSON, Mats O

    “…The aim of this study was to assess the type I error rate when applying the likelihood ratio (LR) test, for components of the statistical sub-model in NONMEM…”
    Get full text
    Journal Article